Equities research analysts forecast that Cigna Corp (NYSE:CI) will post $3.73 earnings per share for the current fiscal quarter, according to Zacks Investment Research. Six analysts have provided estimates for Cigna’s earnings. The highest EPS estimate is $4.20 and the lowest is $3.59. Cigna reported earnings of $3.89 per share in the same quarter last year, which would indicate a negative year over year growth rate of 4.1%. The business is expected to report its next quarterly earnings results before the market opens on Thursday, August 1st.

According to Zacks, analysts expect that Cigna will report full-year earnings of $16.52 per share for the current year, with EPS estimates ranging from $16.40 to $16.65. For the next year, analysts expect that the company will post earnings of $18.58 per share, with EPS estimates ranging from $18.15 to $18.92. Zacks’ EPS averages are an average based on a survey of research firms that cover Cigna.

Cigna (NYSE:CI) last announced its quarterly earnings data on Thursday, May 2nd. The health services provider reported $3.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.74 by $0.16. The business had revenue of $33.43 billion for the quarter, compared to the consensus estimate of $32.79 billion. Cigna had a net margin of 4.11% and a return on equity of 14.23%. Cigna’s quarterly revenue was up 192.9% on a year-over-year basis. During the same quarter last year, the company posted $4.11 earnings per share.

Several equities research analysts have recently issued reports on CI shares. Citigroup upgraded shares of Atara Biotherapeutics from a “sell” rating to a “neutral” rating and raised their price objective for the stock from $23.00 to $24.00 in a research note on Monday, June 3rd. Barclays set a $24.00 price objective on shares of Tenet Healthcare and gave the stock a “hold” rating in a research note on Wednesday, April 17th. UBS Group set a $36.00 price objective on shares of Halliburton and gave the stock a “buy” rating in a research note on Tuesday, April 23rd. Morgan Stanley set a $207.00 price objective on shares of Alibaba Group and gave the stock a “buy” rating in a research note on Friday, July 12th. Finally, Cantor Fitzgerald restated a “buy” rating and issued a $75.00 price objective on shares of Emergent Biosolutions in a research note on Sunday, April 21st. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and fourteen have assigned a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $217.40.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Clarfeld Financial Advisors LLC acquired a new position in Cigna during the 4th quarter worth approximately $25,000. Lowe Wealth Advisors LLC purchased a new position in shares of Cigna during the first quarter valued at approximately $34,000. Truvestments Capital LLC purchased a new position in shares of Cigna during the first quarter valued at approximately $37,000. Lavaca Capital LLC purchased a new position in shares of Cigna during the first quarter valued at approximately $40,000. Finally, C J Advisory Inc purchased a new position in shares of Cigna during the first quarter valued at approximately $40,000. Hedge funds and other institutional investors own 87.94% of the company’s stock.

Shares of Cigna stock traded up $0.75 during midday trading on Friday, hitting $167.30. The company had a trading volume of 1,801,687 shares, compared to its average volume of 2,109,641. The company’s 50 day moving average price is $164.54. The company has a market cap of $63.48 billion, a PE ratio of 11.77, a PEG ratio of 0.87 and a beta of 0.71. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.89. Cigna has a 1-year low of $141.95 and a 1-year high of $226.60.

Cigna Company Profile

Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.

Further Reading: What is the definition of arbitrage?

Get a free copy of the Zacks research report on Cigna (CI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.